Compile Data Set for Download or QSAR
Report error Found 1106 Enz. Inhib. hit(s) with Target = 'Myeloperoxidase'
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM217354(2-(3,5-bistrifluoromethylbenzylamino)-6-oxo-1H-pyr...)
Affinity DataKd:  15.8nMpH: 5.0Assay Description:Binding kinetics were determined by surface plasmon resonance (SPR) using a Biacore S51 (Biacore, Uppsala, Sweden). MPO (50 μg/ml dissolved in 1...More data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM217355(4-benzyl-2-hydroxybenzenecarbohydroxamic acid (HX2...)
Affinity DataKd:  63nMpH: 5.0Assay Description:Binding kinetics were determined by surface plasmon resonance (SPR) using a Biacore S51 (Biacore, Uppsala, Sweden). MPO (50 μg/ml dissolved in 1...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM217356(2-(benzylamino)-6-oxo-3H-pyrimidine-5-carbohydroxa...)
Affinity DataKd:  2.00E+3nMpH: 5.0Assay Description:Binding kinetics were determined by surface plasmon resonance (SPR) using a Biacore S51 (Biacore, Uppsala, Sweden). MPO (50 μg/ml dissolved in 1...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50008371(CHEMBL127385 | H-Thi-Lys-AspMet-GIn-Leu-Gly-Arg-OH)
Affinity DataEC50:  2.00E+5nMAssay Description:In vivo potency as the maximal lysosomal myeloperoxidase (MPO) release in PMNL assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50008373(CHEMBL439468 | H-Leu-Arg-Ala-Asn-Ile-Ser-Phe-Lys-A...)
Affinity DataEC50:  6.00E+4nMAssay Description:In vivo potency as the maximal lysosomal myeloperoxidase (MPO) release in PMNL assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50008382(CHEMBL2370691 | Ac-Phe-Lys-AspMet-GIn-Leu-Gly-Arg-...)
Affinity DataEC50:  3.50E+4nMAssay Description:In vivo potency as the maximal lysosomal myeloperoxidase (MPO) release in PMNL assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50008381(CHEMBL441393 | H-Ile-Ser-Phe-Lys-AspMet-GIn-Leu-Gl...)
Affinity DataEC50:  6.00E+4nMAssay Description:In vivo potency as the maximal lysosomal myeloperoxidase (MPO) release in PMNL assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50008383(CHEMBL408929 | H-Ala-Asn-Ile-Ser-Phe-Lys-AspMet-GI...)
Affinity DataEC50:  3.30E+5nMAssay Description:In vivo potency as the maximal lysosomal myeloperoxidase (MPO) release in PMNL assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50015089(Salicylic hydroxamic acid | SALICYLHYDROXAMIC ACID...)
Affinity DataKd:  2.00E+3nMAssay Description:Binding affinity to recombinant human myeloperoxidaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50229897(CHEMBL314007)
Affinity DataEC50: <3.00E+3nMAssay Description:Compound was tested for the induction of nonspecific myeloperoxidase (MPO) releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50229902(CHEMBL313562)
Affinity DataEC50: <3.00E+3nMAssay Description:Compound was tested for the induction of nonspecific myeloperoxidase (MPO) releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM55880(MLS000737665 | cid_5773323 | (E)-N-(4-amino-2-meth...)
Affinity DataEC50: <3.00E+3nMAssay Description:Compound was tested for the induction of nonspecific myeloperoxidase (MPO) releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50229909(CHEMBL83403)
Affinity DataEC50: 15.00E+3nMAssay Description:Compound was tested for the induction of nonspecific myeloperoxidase (MPO) releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50229904(CHEMBL87465)
Affinity DataEC50: <3.00E+3nMAssay Description:Compound was tested for the induction of nonspecific myeloperoxidase (MPO) releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50444748(Aminoquinuride)
Affinity DataEC50: <3.00E+3nMAssay Description:Compound was tested for the induction of nonspecific myeloperoxidase (MPO) releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM92469(2-Thioxanthine, TX4)
Affinity DataKd:  6.31E+4nMAssay Description:Displacement of benzhydroxamic acid from native state MPO (unknown origin) by 1D NMR reporter assayMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM92467(2-Thioxanthine, TX2)
Affinity DataKd:  2.00E+4nMAssay Description:Displacement of benzhydroxamic acid from native state MPO (unknown origin) by 1D NMR reporter assayMore data for this Ligand-Target Pair
In DepthDetails
PubMedPDB3D3D Structure (crystal)
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM312244(1-[2-(Aminomethyl)-4-chlorobenzyl]-2-thioxo-1,2,3,...)
Affinity DataKd:  3.98E+3nMAssay Description:Displacement of benzhydroxamic acid from native state MPO (unknown origin) by 1D NMR reporter assayMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50595661(CHEMBL5197968)
Affinity DataKd:  631nMAssay Description:Displacement of benzhydroxamic acid from native state MPO (unknown origin) by 1D NMR reporter assayMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM312172(Alternative Preparation | US9616063, 3 | US1001643...)
Affinity DataKd:  501nMAssay Description:Displacement of benzhydroxamic acid from native state MPO (unknown origin) by 1D NMR reporter assayMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50554034(CHEMBL4747269)
Affinity DataIC50: 1nMAssay Description:Inhibition of recombinant human MPO incubated for 10 mins in presence of 120 mM NaCl by aminophenyl fluorescein based assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50554035(CHEMBL4790231)
Affinity DataIC50: 1nMAssay Description:Inhibition of MPO (unknown origin) chlorination activity incubated for 10 mins followed by NaCl addition by aminophenyl fluorescein assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM676534(US20240166642, Example 19b)
Affinity DataIC50: 1.30nMAssay Description:The experiments were performed in phosphate-buffered saline (PBS), pH7.4. A 10 mM luminol (A4695, Sigma Aldrich, St Louis, MO, USA) stock was prepare...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50554035(CHEMBL4790231)
Affinity DataIC50: 1.40nMAssay Description:Inhibition of recombinant human MPO incubated for 10 mins in presence of 120 mM NaCl by aminophenyl fluorescein based assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM312172(Alternative Preparation | US9616063, 3 | US1001643...)
Affinity DataIC50: 1.5nMAssay Description:Inhibition of MPO (unknown origin) measured after 15 mins in presence of H2O2 by chemiluminescence assayMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM676519(US20240166642, Example 10b)
Affinity DataIC50: 1.5nMAssay Description:The experiments were performed in phosphate-buffered saline (PBS), pH7.4. A 10 mM luminol (A4695, Sigma Aldrich, St Louis, MO, USA) stock was prepare...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM312172(Alternative Preparation | US9616063, 3 | US1001643...)
Affinity DataIC50: 1.60nMAssay Description:Inhibition of MPO (unknown origin) measured after 15 mins in presence of H2O2 by chemiluminescence assayMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50554052(CHEMBL4763667)
Affinity DataIC50: 2nMAssay Description:Inhibition of recombinant human MPO incubated for 10 mins in presence of 120 mM NaCl by aminophenyl fluorescein based assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM676505(US20240166642, Example 1b)
Affinity DataIC50: 2.10nMAssay Description:The experiments were performed in phosphate-buffered saline (PBS), pH7.4. A 10 mM luminol (A4695, Sigma Aldrich, St Louis, MO, USA) stock was prepare...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM676524(US20240166642, Example 13b)
Affinity DataIC50: 2.30nMAssay Description:The experiments were performed in phosphate-buffered saline (PBS), pH7.4. A 10 mM luminol (A4695, Sigma Aldrich, St Louis, MO, USA) stock was prepare...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM676522(US20240166642, Example 12b)
Affinity DataIC50: 2.70nMAssay Description:The experiments were performed in phosphate-buffered saline (PBS), pH7.4. A 10 mM luminol (A4695, Sigma Aldrich, St Louis, MO, USA) stock was prepare...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM676532(US20240166642, Example 18b)
Affinity DataIC50: 2.70nMAssay Description:The experiments were performed in phosphate-buffered saline (PBS), pH7.4. A 10 mM luminol (A4695, Sigma Aldrich, St Louis, MO, USA) stock was prepare...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM676514(US20240166642, Example 6b)
Affinity DataIC50: 2.80nMAssay Description:The experiments were performed in phosphate-buffered saline (PBS), pH7.4. A 10 mM luminol (A4695, Sigma Aldrich, St Louis, MO, USA) stock was prepare...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50554050(CHEMBL4752248)
Affinity DataIC50: 2.90nMAssay Description:Inhibition of recombinant human MPO incubated for 10 mins in presence of 120 mM NaCl by aminophenyl fluorescein based assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50432573(CHEMBL2347170)
Affinity DataIC50: 3nMAssay Description:Inhibition of human recombinant MPO-mediated taurine chlorination after 5 mins by microplate assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM676508(US20240166642, Example 3a)
Affinity DataIC50: 3nMAssay Description:The experiments were performed in phosphate-buffered saline (PBS), pH7.4. A 10 mM luminol (A4695, Sigma Aldrich, St Louis, MO, USA) stock was prepare...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM676543(US20240166642, Example 28)
Affinity DataIC50: 3nMAssay Description:The experiments were performed in phosphate-buffered saline (PBS), pH7.4. A 10 mM luminol (A4695, Sigma Aldrich, St Louis, MO, USA) stock was prepare...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM676530(US20240166642, Example 17b)
Affinity DataIC50: 3.40nMAssay Description:The experiments were performed in phosphate-buffered saline (PBS), pH7.4. A 10 mM luminol (A4695, Sigma Aldrich, St Louis, MO, USA) stock was prepare...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50595667(CHEMBL5181350)
Affinity DataIC50: 3.60nMAssay Description:Inhibition of MPO (unknown origin) measured after 15 mins in presence of H2O2 by chemiluminescence assayMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM676507(US20240166642, Example 2b)
Affinity DataIC50: 3.60nMAssay Description:The experiments were performed in phosphate-buffered saline (PBS), pH7.4. A 10 mM luminol (A4695, Sigma Aldrich, St Louis, MO, USA) stock was prepare...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM676528(US20240166642, Example 16b)
Affinity DataIC50: 3.90nMAssay Description:The experiments were performed in phosphate-buffered saline (PBS), pH7.4. A 10 mM luminol (A4695, Sigma Aldrich, St Louis, MO, USA) stock was prepare...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50432575(CHEMBL2347168)
Affinity DataIC50: 4nMAssay Description:Inhibition of human recombinant MPO-mediated taurine chlorination after 5 mins by microplate assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50507392(CHEMBL4548537 | US10981879, Example 11)
Affinity DataIC50: 4.60nMAssay Description:Inhibition of human PMN leukocytes MPO peroxidation activity using H2O2 as substrate preincubated for 10 mins followed by H2O2 addition and measured ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50332590(5-(5-fluoro-1H-indol-3-yl)pentan-1-amine | CHEMBL1...)
Affinity DataIC50: 5nMAssay Description:Inhibition of recombinant MPO mediated LDL oxidation using MPO/Cl-/H2O2 systemMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50432568(CHEMBL2347177)
Affinity DataIC50: 5nMAssay Description:Inhibition of human recombinant MPO-mediated taurine chlorination after 5 mins by microplate assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50238843(CHEMBL4068067)
Affinity DataIC50: 5nMAssay Description:Inhibition of recombinant MPO (unknown origin) assessed as reduction in taurine chloramine production preincubated with enzyme and taurine followed b...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50332590(5-(5-fluoro-1H-indol-3-yl)pentan-1-amine | CHEMBL1...)
Affinity DataIC50: 5nMAssay Description:Inhibition of recombinant MPO (unknown origin) assessed as reduction in taurine chloramine production preincubated with enzyme and taurine followed b...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50554057(CHEMBL4740830)
Affinity DataIC50: 5nMAssay Description:Inhibition of recombinant human MPO incubated for 10 mins in presence of 120 mM NaCl by aminophenyl fluorescein based assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM434866(US10577383, Example 26 | 7-[(3R,4S,6S,10R)-4-Benzy...)
Affinity DataIC50: 5nMAssay Description:Inhibition of MPO (unknown origin) chlorination activity incubated for 10 mins followed by NaCl addition by aminophenyl fluorescein assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetMyeloperoxidase(Human)
University of Otago Christchurch

LigandPNGBDBM50595661(CHEMBL5197968)
Affinity DataIC50: 5nMAssay Description:Inhibition of MPO (unknown origin) measured after 15 mins in presence of H2O2 by chemiluminescence assayMore data for this Ligand-Target Pair
In DepthDetails
PubMed
Displayed 1 to 50 (of 1106 total ) | Next | Last >>
Jump to: